[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

William M. Moore, a director of Iridex Corporation (IRIX), reported purchases of the company’s common stock on 08/18/2025. The filing shows he acquired 12,024 shares at a weighted average price of $1.1834 per share (prices ranged from $1.175 to $1.1899). After the purchases, Mr. Moore directly beneficially owned 200,674 shares. The filing also discloses indirect holdings of 69,300 shares held by his spouse and 30,026 shares held in two trusts where he and his spouse serve as trustees/tenants in common. The Form 4 was signed on behalf of Mr. Moore by an attorney-in-fact on 08/19/2025.

Positive

• Insider purchase disclosed: Director acquired 12,024 shares, increasing direct stake to 200,674 shares, enhancing transparency
• Price transparency: Filing provides weighted average price $1.1834 and range $1.175–$1.1899 and offers to disclose per-transaction prices

Negative

• None.

Insights

Securities Analyst

TL;DR: Director purchased 12,024 IRIX shares at ~$1.18, modestly increasing direct ownership to 200,674 shares.

The purchase is a routine insider acquisition disclosed on a Form 4. The weighted average price and disclosed price range are provided, and the filing separates direct and indirect holdings including spouse and trust ownership. There are no derivative transactions or other material changes reported. This disclosure provides transparency on insider ownership but does not, by itself, signal a material corporate event.

Corporate Governance Expert

TL;DR: Governance disclosure is complete for this transaction; ownership structure and trustee details are specified.

The Form 4 identifies the reporting person as a director and details both direct and indirect beneficial ownership, including trusts with specific dates. The filing includes an explanation of the weighted average purchase price and a statement offering to provide per-price allocation if requested. Signature was executed by an attorney-in-fact, as noted.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORE WILLIAM M

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		P		12,024	A	$1.1834(1)	200,674	D
Common Stock								69,300	I	By Spouse
Common Stock								30,026	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.1899, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

2. The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.

	/s/ Nilo De Castro, Attorney-in-fact for William Moore	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IRIX director William M. Moore purchase on 08/18/2025?

He purchased 12,024 shares of Iridex common stock at a weighted average price of $1.1834 per share, with transaction prices ranging $1.175 to $1.1899.

How many IRIX shares does William M. Moore beneficially own after the Form 4 filing?

Direct beneficial ownership is 200,674 shares following the reported purchases; additional indirect holdings are disclosed separately.

Are there any indirect holdings related to William M. Moore in the filing?

Yes. The filing shows 69,300 shares indirectly held by his spouse and 30,026 shares held in two trusts where he and his spouse are tenants in common/trustees.

Was the Form 4 signed by William Moore himself?

No. The signature block shows the form was signed by an attorney-in-fact, Nilo De Castro, on 08/19/2025.

Did the Form 4 report any derivative transactions for IRIX?

No. Table II for derivative securities contains no reported transactions.